We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Analysis

4 Fast Facts As FDA Clears 'Historic' Novartis Therapy

Law360, New York (August 30, 2017, 7:53 PM EDT) -- The U.S. Food and Drug Administration on Wednesday cleared Novartis AG’s first-of-its-kind gene therapy, declaring the approval “historic” and an “inflection point” for cancer treatment. Here are four fast facts about...
To view the full article, register now.